Analyst Activity – Credit Suisse Group Reiterates Neutral on GlaxoSmithKline plc (LON:GSK)

ME Staff
-
0

Analyst Ratings For GlaxoSmithKline plc (LON:GSK)

Today, Credit Suisse Group reiterated its Neutral rating on GlaxoSmithKline plc (LON:GSK) with a price target of GBX 1,775.

There are 4 sell ratings, 11 hold ratings, 8 buy ratings on the stock.

The current consensus rating on GlaxoSmithKline plc (LON:GSK) is Hold (Score: 2.17) with a consensus target price of GBX 1,737 per share, a potential .

Some recent analyst ratings include

  • 7/27/2017-Credit Suisse Group Reiterated Rating of Neutral.
  • 7/27/2017-Kepler Capital Markets Reiterated Rating of Reduce.
  • 7/27/2017-Barclays PLC Reiterated Rating of Equal weight.
  • 7/27/2017-Liberum Capital Reiterated Rating of Buy.
  • 7/26/2017-Investec Reiterated Rating of Buy.
  • 7/26/2017-Berenberg Bank Reiterated Rating of Buy.


    Recent Trading Activity for GlaxoSmithKline plc (LON:GSK)
    Shares of GlaxoSmithKline plc closed the previous trading session at 1,532.53 down -12.97 -0.84% with 10,819,078 shares trading hands.